Rapid and remarkable effectiveness of benralizumab for treating severe bronchial asthma with intractable eosinophilic rhinosinusitis and eosinophilic otitis media: A case report
Severe bronchial asthma is a challenging disorder to treat and can impair quality of life (QOL) under conventional therapeutic modalities. We report the case of a 52-year-old woman with severe asthma associated with eosinophilic chronic rhinosinusitis (ECRS) and eosinophilic otitis media (EOM). Alth...
Main Authors: | Hideyasu Shimizu, Hisayuki Kato, Satoshi Yoshioka, Mitsushi Okazawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007120305505 |
Similar Items
-
Successful treatment of eosinophilic chronic rhinosinusitis and eosinophilic otitis media using the anti-IL-5 receptor monoclonal antibody benralizumab: A case report
by: Hiroki Kagoshima, et al.
Published: (2020-01-01) -
Efficacy and use of benralizumab in patients with eosinophilic chronic rhinosinusitis
by: G.L. Fadda, et al.
Published: (2021-03-01) -
A case of recurrent chronic eosinophilic pneumonia after switching from benralizumab to dupilumab
by: Daiki Nakashima, et al.
Published: (2024-01-01) -
Effect of dupilumab on otitis media associated with eosinophilic chronic rhinosinusitis
by: Seiichiro Kamimura, et al.
Published: (2025-03-01) -
Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis
by: Daiki Nakashima, et al.
Published: (2023-10-01)